Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. [electronic resource]
Producer: 19850425Description: 608-16 p. digitalISSN:- 0022-3565
- (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride -- pharmacology
- Acetylcholine -- pharmacology
- Adenylyl Cyclase Inhibitors
- Animals
- Atropine -- pharmacology
- Benzodiazepinones -- pharmacology
- Brain -- metabolism
- Carbachol -- pharmacology
- In Vitro Techniques
- Inositol -- analogs & derivatives
- Inositol Phosphates
- Male
- Myocardium -- metabolism
- Oxotremorine -- pharmacology
- Parotid Gland -- metabolism
- Phosphatidylinositols -- metabolism
- Pirenzepine
- Quinuclidinyl Benzilate -- metabolism
- Radioligand Assay
- Rats
- Rats, Inbred Strains
- Receptors, Muscarinic -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.